loading animation for AJAX calls

239 Reports in Biotechnology

Proteomics: Technologies and Global Markets

Published - Oct 2018 | Analyst - Bhavna Joshi| Code - BIO034E

The global market for proteomics should grow from $7.9 billion in 2017 to $16.8 billion by 2022 at a compound annual growth rate (CAGR) of 16.2% for the period of 2017-2022.

Protein Analysis: Subfocus on Oncoproteomics

Published - Oct 2018 | Analyst - Anuj Pathak| Code - BIO168A

The global market for protein analysis should grow from $11.6 billion in 2018 to $19.0 billion by 2023 at a compound annual growth rate (CAGR) of 10.4% from 2018 through 2023.

Genetic Modification Therapies Clinical Applications: Gene Thera...

Published - Sep 2018 | Analyst - John Bergin| Code - BIO159A

The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.

Biomarkers: Technologies and Global Markets

Published - Sep 2018 | Analyst - BCC Research Staff| Code - BIO061E

The global market for biomarkers should grow from $78.9 billion in 2018 to $136.5 billion by 2023 at a compound annual growth rate (CAGR) of 11.6% from 2018 through 2023.

Next Generation Sequencing for Non-invasive Prenatal Testing: Glo...

Published - Sep 2018 | Analyst - BCC Research Staff| Code - BIO173A

The global market for non-invasive prenatal testing (NIPT) should grow from $1.9 billion in 2018 to reach $3.1 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2018-2023.

Global Markets for Enzymes in Industrial Applications

Published - Sep 2018 | Analyst - BCC Research Staff| Code - BIO030K

The global industrial enzymes market should reach $7.0 billion by 2023 from $5.5 billion in 2018 at a compound annual growth rate (CAGR) of 4.9% for the period 2018-2023.

Switching to CRISPR-Cas Systems from Uncultivated Microbes

Published - Sep 2018 | Analyst - Mike (Ke Ke) Fan| Code - BIO172A

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is currently the biggest discovery in life science. As a precise gene editing tool, it has been widely used in many areas with a great potential to treat human diseases. While some CRISPR-based therapeutic studies are moving to clinical trials, CRISPR's therapeutic promise was brought into question when some issues were found that could become major obstacles in moving the great genome editing tools to the clinic.While many groups are actively resolving these obstacles, the significant challenges to minimize the immunological risks and avoid potential tumorgenicity have received more attention as big concerns for CRISPR-Cas therapeutics advancing toward the clinic. We believe it is timely to summarize and analyze the emerging immunological risk and potential tumorgenicity with the CRISPR-Cas systems, to predict how this exciting genome editing market will affect other related segments of the entire life science market in the next few years. We also hope our opinion could serve as a "crowd crystal" on those discussions in response to the issues, and bring a better market environment for the technology to be sharpened and advanced into clinical applications.

Current Research & Developments Status of Chimeric Antigen Recept...

Published - Aug 2018 | Analyst - Paul Taylor| Code - BIO162A

The global market for Chimeric Antigen Receptor (CAR) T-cell therapies will grow from nearly $467.0 million in 2018 to $2.9 billion by 2023 at a compound annual growth rate (CAGR) of 44.1% for the period of 2018-2023.

Adoptive Transfer of Autologous Lymphocytes Targeting Somatically...

Published - Aug 2018 | Analyst - Paul Taylor| Code - BIO171A

Adoptive Cell Therapies (ACTs) and the infusion of autologous or redirected tumor-specific T-cells have the potential to drastically impact the treatment of a variety of cancers, especially common epithelial cancers. This report summarizes the current state of clinical research and trials, explains the impact of ACTs on the treatment of several metastasized malignancies, and also raises important concerns about the scalability and compatibility of TILs.

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnosti...

Published - Aug 2018 | Analyst - Todd Graham| Code - BIO157A

The global market for polymerase chain reaction (PCR) in point of care (POC) diagnostics totaled $2.9 billion in 2018 and is estimated to reach $4.8 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.6% for the period of 2018-2023.

Microbial Products: Technologies, Applications and Global Markets

Published - Aug 2018 | Analyst - Andrew McWilliams| Code - BIO086D

The global microbes and microbial products market should reach $302.4 billion by 2023 from $186.3 billion in 2018 at a compound annual growth rate (CAGR) of 10.2% for the period 2018-2023.

Immunohistochemistry (IHC): Global Markets to 2022

Published - Aug 2018 | Analyst - Vijay Laxmi| Code - BIO161A

The global immunohistochemistry market totaled $1.6 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.8% for the period of 2017-2022.

Global Markets for Media, Sera and Reagents in Biotechnology

Published - Aug 2018 | Analyst - BCC Research Staff| Code - BIO014K

The global market for media, sera and reagents in biotechnology should reach $5.5 billion by 2023 from $4.1 billion in 2018 at a compound annual growth rate (CAGR) of 6.0% for the period 2018-2023.

Synthetic Biology: Global Markets

Published - Jul 2018 | Analyst - John Bergin| Code - BIO066E

The global market for synthetic biology will grow from nearly $4.4 billion in 2017 to $13.9 billion by 2022, with a compound annual growth rate (CAGR) of 26.0% for the period of 2017-2022.

Cardiac Biomarkers: Technologies and Global Markets

Published - Jul 2018 | Analyst - Paul Taylor| Code - BIO128C

The global market for cardiac biomarker will grow from $6.3 billion in 2017 to $9.9 billion by 2022, at a compound annual growth rate (CAGR) of 9.5% for the period of 2017-2022

Digital Polymerase Chain Reaction (PCR) Technology: Global Market...

Published - Jun 2018 | Analyst - Todd Graham| Code - BIO137B

The global digital polymerase chain reaction (PCR) technology market totaled $425.0 million in 2017 and is estimated to reach $746.0 million by 2022, growing at a compound annual growth rate (CAGR) of 11.9% for the period of 2017-2022.

Exosome Diagnostics and Therapeutics: Global Markets

Published - Jun 2018 | Analyst - Marianna Tcherpakov| Code - BIO149B

The global market for exosome industry should reach $180.0 million by 2023 from $25 million in 2018 at a compound annual growth rate (CAGR) of 48.4% for the period 2018-2023.

The Chinese Market for DNA Sequencing

Published - Jun 2018 | Analyst - Jason Chen| Code - BIO152B

The Chinese market for DNA sequencing totaled $1.2 billion in 2017. The market should total $2.9 billion by 2022, growing at a compound annual growth rate (CAGR) of 19.0% during 2017-2022.

Biosimilars: Global Markets

Published - Apr 2018 | Analyst - Kamna Jhamb| Code - BIO090C

The global biosimilars market reached nearly $5.5 billion in 2017 and is expected to reach $20.8 billion by 2022, with a compound annual growth rate (CAGR) of 30.5% from 2017 through 2022.

Artificial Blood: Global Markets to 2027

Published - Apr 2018 | Analyst - BCC Research Staff| Code - BIO164A

The global market for potential artificial blood is estimated to grow from nearly $6.2 billion in 2022 to $15.6 billion by 2027 with a compound annual growth rate (CAGR) of 20.5% for the period of 2022-2027.

Cell Therapy Processing: Global Markets and Technologies

Published - Apr 2018 | Analyst - Sangeeta Rai| Code - BIO160A

The global market for cell therapy reached $1.3 billion in 2017 and should reach $5.0 billion in 2022 at a compound annual growth rate (CAGR) of 30.9% for the period of 2017-2022.

The Global Market for Stem Cells

Published - Apr 2018 | Analyst - Paul Evers| Code - BIO035G

The global market for stem cells totaled $7.4 billion in 2017 and is estimated to reach $14.8 billion by 2022, growing at a compound annual growth rate (CAGR) of 14.7% for the period of 2017-2022.

Biologics Development and Manufacturing Testing: Technologies and...

Published - Mar 2018 | Analyst - David Peters| Code - BIO155A

The global biological safety testing market should reach $13.1 billion by 2022 from $5.1 billion in 2017 at a compound annual growth rate (CAGR) of 20.9%, from 2017 to 2022.

Mobile Apps for DNA Sequencing: Global Markets

Published - Mar 2018 | Analyst - Smruti Munshi| Code - BIO156A

The global market for mobile applications for DNA sequencing reached $28.8 billion in 2017. The market should reach $248.3 billion by 2022, at a compound annual growth rate (CAGR) of 53.8% during 2017-2022.

Drug Discovery Technologies

Published - Feb 2018 | Analyst - Shalini Shahani Dewan| Code - BIO020F

The global market for drug discovery technologies totaled $54.7 billion in 2017. The market should reach $85.8 billion by 2022, growing at a compound annual growth rate (CAGR) of 9.4% during 2017-2022.

« 1 2 3 4 5 »

10 Upcoming Reports in Biotechnology

Global Longevity and Anti-senescence Therapy market

Target Date - May 2019| Author - Sathya Durga| Code - BIO185A| Price - $5,500

Report Includes

  • An overview of the global longevity and anti-senescence therapy market
  • Analyses of global market trends, with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Detailed description of different therapies such as senolytic drug therapy, gene therapy, and immunotherapy and discussion on how these slow down or reverse aging process
  • Coverage of drugs, devices and technologies and information about the various compounds used for the development of anti-ageing therapeutics
  • A look at the clinical trials and expected launch of anti-senescence products
  • Detailed profiles of the major vendors and potential entrants in the global longevity and anti-senescence therapy market

Notify Me

Global Microbiome Sequencing Market

Target Date - Jun 2019| Author - Anuj Pathak| Code - BIO183A| Price - $5,500

Report Includes

  • An overview of the global market and technologies for genome sequencing
  • Analyses of global market trends, with data from 2017, 2018 and projections of CAGRs through 2023
  • Analysis of the present and future opportunities and key factors influencing the in-microbiome sequencing market
  • Discussion on impact of genome sequencing on pharmaceutical, biotechnology and healthcare sectors
  • Information on automated instruments and discussion on how it facilitates speedy sequencing procedures
  • Insights into government initiatives and funding for the development of effective drugs for the treatment and prevention from chronic diseases
  • Company profiles of the major players of the market

Notify Me

 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM